Metformin reduces weight, centripetal obesity, insulin, leptin, and low-density lipoprotein cholesterol in nondiabetic, morbidly obese subjects with body mass index greater than 30GLUECK, C. J; FONTAINE, R. N; MCCULLOUGH, P et al.Metabolism, clinical and experimental. 2001, Vol 50, Num 7, pp 856-861, issn 0026-0495Article

Hypofibrinolytic and atherogenic risk factors for strokeGLUECK, C. J; RORICK, M. H; SCHMERLER, M et al.The Journal of laboratory and clinical medicine. 1995, Vol 125, Num 3, pp 319-325, issn 0022-2143Article

Measurement of plasminogen activator inhibitor type 1 antigen : comparison of Tintelize and Imubind methodsSTROOP, D. M; GLUECK, C. J; TRACY, T. M et al.Blood coagulation & fibrinolysis. 1994, Vol 5, Num 6, pp 865-872, issn 0957-5235Conference Paper